Retatrutide is a new treatment in the fight against obesity. This groundbreaking drug, categorized as a dual GLP-1 and GIP receptor agonist, shows promising results in clinical trials. By boosting these receptors, https://lillipqjc474795.blog2freedom.com/36181450/setmelanotide-a-promising-new-treatment-for-obesity